A major step toward simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to ...

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...

FDA’s focus on playing a direct role in lowering drug prices may provide opportunities for some pharmaceutical companies to seek a regulatory advantage. But it also places enormous pressure on ...

Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an ...

MEXICO CITY—Mexico’s government said it transferred 37 people with alleged ties to drug cartels to U.S. authorities, the latest handover as pressure from the Trump administration mounts to intensify ...

Jan 14 (Reuters) - The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible use of artificial intelligence in developing medicines, ...

Microneedle-based transdermal drug delivery is a rapidly evolving area at the intersection of materials science, pharmacology, and medical technology.